company_name|source_name|scraping_datetime|article_url|article_datetime|article_title|article_text
Union Pacific|scrape_standardized_cnbc|2020-10-17 12:54:46|https://www.cnbc.com/2020/07/17/cramer-week-ahead-big-week-for-earnings-even-bigger-week-for-vaccines.html?&qsearchterm=Union Pacific|Published Fri, Jul 17 20207:25 PM EDT|Cramer’s week ahead: Big week for earnings, even bigger week for vaccines|With earnings season in earnest, vaccine news will paint the market more than the top- and bottom-line results companies are scheduled to post next week, CNBC’s Jim Cramer said Friday.The Lancet, a respected weekly medical journal, is set on Monday to publish phase one data from a vaccine study performed by AstraZeneca and Oxford University, which are currently undertaking a phase three human trial. Cramer is convinced that the news could be bigger than results Moderna published on its own study earlier this week.“Big week for earnings. Even bigger week for vaccines. They hold the key, not companies,” the “Mad Money” host said. “We’ll pay more for the earnings of the non-Covid companies if The Lancet publishes some good news from AstraZeneca’s vaccine trial. End of story.”Trading was mixed Friday in a relatively sedate day on Wall Street. The Dow Jones slipped almost 63 points, or 0.23%, to 26,671.95 during the session. The S&P 500 rose 0.28% to 3,224.73, and the Nasdaq Composite advanced 0.28%.Cramer revealed the earnings reports he has circled on his calendar in the week to come. All projections are based on Factset estimates:
